Skip to content Print

MedixMAB Neuron-Specific Enolase (NSE)

MedixMAB tumors markers include clones for NSE as well

About NSE / Neuron-Specific Enolase

Neuron-specific enolase (NSE) has been detected in patients with certain tumors, namely: neuroblastoma, small cell lung cancer, medullary thryroid cancer, carcinoid tumors, pancreatic endocrine tumors, and melanoma. Studies of NSE as a tumor marker have concentrated primarly on patients with neuroblastoma and small cell lung cancer. Measurement of NSE levels in patients with these two diseases can provide information about the extent of the disease and the patient's prognosis, as well as about the patient's response to treatment.

 

NEW!

 

The shelf life of NSE 9601 extended from 12 to 36 months!

 

 

Product Specification Sheets

Product name   

Product Code

Product Specification Sheet

  • Anti-h NSE clone 9601  

100115

  • Anti-h NSE clone 9602

100116



Back to top